Johan Strömqvist
Direktor/Vorstandsmitglied bei NEWBURY PHARMACEUTICALS AB
Profil
Johan Strömqvist is the founder of Single Technologies AB, where he holds the titles of President & Director since 2014.
He is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Dr. Strömqvist has a graduate degree from the University of Stockholm and graduate and doctorate degrees from the Royal Institute of Technology.
Aktive Positionen von Johan Strömqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Direktor/Vorstandsmitglied | 01.01.2020 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Gründer | 01.01.2014 |
Ausbildung von Johan Strömqvist
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Commercial Services |
